Biallelic BRCA2 mutations are associated with multiple malignancies in childhood including familial Wilms tumour

FA is characterised by variable congenital abnormalities, short stature, bone marrow failure, hypersensitivity to DNA crosslinking agents, and a predisposition to haematological malignancies such as acute myeloid leukaemia in childhood. 5 FA is heterogeneous and consists of at least 11 complementati...

Full description

Saved in:
Bibliographic Details
Published inJournal of medical genetics Vol. 42; no. 2; pp. 147 - 151
Main Authors Reid, S, Renwick, A, Seal, S, Baskcomb, L, Barfoot, R, Jayatilake, H, Pritchard-Jones, K, Stratton, M R, Ridolfi-Lüthy, A, Rahman, N
Format Journal Article
LanguageEnglish
Published London BMJ Publishing Group Ltd 01.02.2005
BMJ
BMJ Publishing Group LTD
BMJ Group
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:FA is characterised by variable congenital abnormalities, short stature, bone marrow failure, hypersensitivity to DNA crosslinking agents, and a predisposition to haematological malignancies such as acute myeloid leukaemia in childhood. 5 FA is heterogeneous and consists of at least 11 complementation groups, A, B, C, D1, D2, E, F, G, I, J, and L. 6- 8 Eight FA genes have been cloned and at least six FA proteins, FANCA, FANCC, FANCE, FANCF, FANCG, and FANCL, form a nuclear complex required for monoubiquitination of FANCD2. In part this may be because affected children present before their parents, as exemplified by WILMS2, in which the mother and paternal aunt developed breast cancer after the boys had died. [...]although a family history may be helpful in the identification of some biallelic BRCA2 families, it will likely need to extend to at least three generations to detect the cancer history, particularly on the paternal side.
Bibliography:local:0420147
ark:/67375/NVC-PPB3TQFL-3
href:jmedgenet-42-147.pdf
PMID:15689453
istex:8F62DDB2D145351E7601F3BC69C86CD0B16B115C
Correspondence to:
 Dr Nazneen Rahman
 Section of Cancer Genetics, Brookes Lawley Building, Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey SM2 5NG, UK; nazneen.rahman@icr.ac.uk
ISSN:0022-2593
1468-6244
1468-6244
DOI:10.1136/jmg.2004.022673